Tavaborole
Product Images NDC 69097-686

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Tavaborole (NDC 69097-686). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Ac0a7dcc 4cd8 412b 8238 Bbc23aa5cdc6 01)

Chemical structure diagram of the active ingredient in TAVABOROLE, labeled with fluorine and boron-containing groups visible in the ring. The structure depicts the molecular arrangement relevant to the product by Cipla USA Inc.*

FDA Label Image

4ml (Ac0a7dcc 4cd8 412b 8238 Bbc23aa5cdc6 02)

Label for Tavaborole topical solution 5% in a 4 mL bottle, labeled for topical use only and not for oral, ophthalmic, or intravaginal use. The label includes storage instructions, product NDC 69097-686-34, and manufacturing details for Cipla USA Inc. and Encube Ethicals Pvt. Ltd. It has a designated unvarnished area for batch overprinting and clearances for unwinding direction.*

FDA Label Image

4ml (Ac0a7dcc 4cd8 412b 8238 Bbc23aa5cdc6 03)

Packaging label for Tavaborole topical solution 5% by Cipla USA Inc. The label specifies topical use only, not for oral, ophthalmic, or intravaginal use, and contains 4 mL per container. It includes batch overprinting area, barcode, and detailed directions, warnings, and manufacturing information. The product is marked Rx only.*

FDA Label Image

10ml (Ac0a7dcc 4cd8 412b 8238 Bbc23aa5cdc6 04)

The label for Tavaborole Topical Solution 5%, manufactured by Cipla USA Inc. The label states the solution is for topical use only, not for oral, ophthalmic, or intravaginal use. It includes storage instructions and manufacturing details for Encube Ethicals Pvt. Ltd. in India and Cipla USA in New Jersey. The package size is 10 mL.*

FDA Label Image

10ml (Ac0a7dcc 4cd8 412b 8238 Bbc23aa5cdc6 05)

Tavaborole Topical Solution 5% packaging label showing product name, strength, and volume of 10 mL. The label includes usage restrictions stating for topical use only and warnings about not using orally, ophthalmically, or intravaginally. It also mentions the product device contains dry natural rubber. Manufactured by Encube Ethicals Pvt. Ltd. for Cipla USA Inc. The label includes batch overprinting area, barcodes, and storage and caution instructions.*

FDA Label Image

Image (Ac0a7dcc 4cd8 412b 8238 Bbc23aa5cdc6 68 2)

An instructional illustration showing steps to open and use a bottle with a dropper. The first panel depicts a hand twisting the bottle cap to open it, while the second panel shows a hand pulling a dropper out of the bottle. The bottle labels are not legible.*

FDA Label Image

Image (Ac0a7dcc 4cd8 412b 8238 Bbc23aa5cdc6 68 3)

An instructional illustration showing a hand using a dropper to apply liquid medication directly onto a toenail. The image demonstrates the proper technique for topical application of the product onto the nail surface, with another hand holding the toe steady.*

FDA Label Image

Image (Ac0a7dcc 4cd8 412b 8238 Bbc23aa5cdc6 68 4)

An instructional illustration showing a hand applying a liquid medication to a toenail using a dropper. The dropper is positioned over the toenail, indicating topical application of the product.*

FDA Label Image

Image (Ac0a7dcc 4cd8 412b 8238 Bbc23aa5cdc6 68 5)

Illustration showing the application of a liquid medication using a dropper onto a toenail. The steps indicate placing drops at the edge of the nail and gently spreading the liquid around the nail surface with a fingertip in a circular motion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.